The AHA Dec. 17 urged Elevance Health, which is the parent company of the Anthem brand of health plans, to rescind Anthem’s nonparticipating provider policy that is set to go into effect Jan. 1, citing the harm it will inflict on patients.

Effective Jan. 1, 2026, Anthem intends to impose punitive measures on hospitals participating in the plan’s network in instances where an out-of-network provider is part of an Anthem enrollee’s care team. Under the policy, Anthem could penalize hospitals equal to 10% of the allowed amount of the hospital’s claims that involve the use of an out-of-network provider and potentially terminate the hospital from its networks. Penalties and termination can be applied to hospitals under the policy even though hospitals may not own, control or manage independent providers involved in a patient’s care.

“Specifically, Anthem’s approach would limit patients’ choice of providers and could even mislead them about where they can access care,” AHA President and CEO Rick Pollack wrote to Elevance Health.

The AHA strongly urged Elevance to rescind the policy and work directly with applicable out-of-network providers to address their concerns and, if that fails, participate more meaningfully within the No Surprises Act Independent Dispute Resolution process.

“The core objectives of the NSA were to protect patients and to incentivize network participation,” the AHA said. “Anthem undermines this landmark legislation by introducing new patient harms and targeting the very hospitals that have worked in good faith to participate in the plan’s network. The AHA calls on Elevance Health to do right by its Anthem enrollees and ensure it is a credible partner to its network hospitals and health systems and rescind this deeply flawed policy.”

Headline
The Centers for Medicare & Medicaid Services has released a toolkit that outlines strategies for states to strengthen access to behavioral health services…
Headline
The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a possible future…
Headline
The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on the Global Benchmark for Efficient Drug Pricing Model, or…
Headline
The AHA Feb. 17 submitted a comment letter responding to the Centers for Medicare & Medicaid Services’ proposed rule that would prohibit hospitals…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 11 hosted a hearing titled “Lowering Health Care Costs for All Americans: An Examination of the…
Headline
The White House yesterday launched TrumpRx, the direct-to-consumer platform that will serve as a hub to direct cash-paying consumers to drug manufacturers…